본문 바로가기
KERD
논문KCI 등재

Risk Factors for Lymph Node Metastasis and Oncologic Outcomes in Small Rectal Neuroendocrine Tumors with Lymphovascular Invasion

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Background/Aims: Small rectal neuroendocrine tumors (NETs) are often managed with local resection (endoscopic or transanal excision) owing to their low risk of metastasis and recurrence. However, the clinical significance of lymphovascular invasion in resected specimens remains controversial. In this study, we aimed to analyze the frequency of and risk factors for lymph node metastasis proven by histopathologic examination after radical resection. Methods: We retrospectively reviewed the records of 750 patients diagnosed with a rectal NET at four academic medical centers in South Korea between 2001 and 2019. The frequency of histopathologically proven lymph node metastasis and the associated risk factors were analyzed for small tumors (≤1.5 cm) with lymphovascular invasion. Results: Among 750 patients, 75 had a small tumor (≤1.5 cm) with lymphovascular invasion, of whom 31 patients underwent endoscopic resection only and 44 patients underwent additional radical surgery. Among the 41 patients who underwent surgery and had available data, the rate of regional lymph node metastasis was 48.8% (20/41). In multivariate analysis, the Ki-67 index (odds ratio, 6.279; 95% confidence interval, 1.212 to 32.528; p=0.029) was an independent risk factor for lymph node metastasis. During the mean follow-up period of 37.7 months, only one case of recurrence was detected in the surgery group. The overall survival was not significantly different between radical resection and local resection (p=0.332). Conclusions: Rectal NETs with lymphovascular invasion showed a significantly high rate of regional lymph node metastasis despite their small size (≤1.5 cm).

Abstract

Background/Aims: Small rectal neuroendocrine tumors (NETs) are often managed with local resection (endoscopic or transanal excision) owing to their low risk of metastasis and recurrence. However, the clinical significance of lymphovascular invasion in resected specimens remains controversial. In this study, we aimed to analyze the frequency of and risk factors for lymph node metastasis proven by histopathologic examination after radical resection. Methods: We retrospectively reviewed the records of 750 patients diagnosed with a rectal NET at four academic medical centers in South Korea between 2001 and 2019. The frequency of histopathologically proven lymph node metastasis and the associated risk factors were analyzed for small tumors (≤1.5 cm) with lymphovascular invasion. Results: Among 750 patients, 75 had a small tumor (≤1.5 cm) with lymphovascular invasion, of whom 31 patients underwent endoscopic resection only and 44 patients underwent additional radical surgery. Among the 41 patients who underwent surgery and had available data, the rate of regional lymph node metastasis was 48.8% (20/41). In multivariate analysis, the Ki-67 index (odds ratio, 6.279; 95% confidence interval, 1.212 to 32.528; p=0.029) was an independent risk factor for lymph node metastasis. During the mean follow-up period of 37.7 months, only one case of recurrence was detected in the surgery group. The overall survival was not significantly different between radical resection and local resection (p=0.332). Conclusions: Rectal NETs with lymphovascular invasion showed a significantly high rate of regional lymph node metastasis despite their small size (≤1.5 cm).

참고문헌 (32)

  1. Dasari A, "Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States", JAMA Oncol, 3, pp.1335~1342 (2017)
  2. Sackstein PE, "Epidemiologic trends in neuroendocrine tumors : an examination of incidence rates and survival of specific patient subgroups over the past 20 years", Semin Oncol, 45, pp.249~258 (2018)
  3. 조미연, "Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study", Cancer Research and Treatment, 44(3), pp.157~165 (2012), 대한암학회[DOI]
  4. Yao JC, "One hundred years after"carcinoid" : epidemiology of and prognostic factors for neuroendocrine tumors in 35, 825 cases in the United States", J Clin Oncol, 26, pp.3063~3072 (2008)
  5. Bertani E, "Neuroendocrine neoplasms of rectum : a management update", Cancer Treat Rev, 66, pp.45~55 (2018)
  6. Nakamura K, "Short-and long-term outcomes of endoscopic resection of rectal neuroendocrine tumours : analyses according to the WHO 2010 classification", Scand J Gastroenterol, 51, pp.448~455 (2016)
  7. Ramage JK, "ENETS consensus guidelines update for colorectal neuroendocrine neoplasms", Neuroendocrinology, 103, pp.139~143 (2016)
  8. Anthony LB, "The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors(NETs) : welldifferentiated nets of the distal colon and rectum", Pancreas, 39, pp.767~774 (2010)
  9. Kunz PL, "Consensus guidelines for the management and treatment of neuroendocrine tumors", Pancreas, 42, pp.557~577 (2013)
  10. "Neuroendocrine and adrenal tumors (version 2.2020)" (2020)[URL]
  11. Shreya Chablaney, "Diagnosis and Management of Rectal Neuroendocrine Tumors", Clinical Endoscopy, 50(6), pp.530~536 (2017), 대한소화기내시경학회
  12. 소훈섭, "Efficacy of Precut Endoscopic Mucosal Resection for Treatment of Rectal Neuroendocrine Tumors", Clinical Endoscopy, 50(6), pp.585~591 (2017), 대한소화기내시경학회
  13. de Mestier L, "Updating the management of patients with rectal neuroendocrine tumors", Endoscopy, 45, pp.1039~1046 (2013)
  14. Sekiguchi M, "Excellent prognosis following endoscopic resection of patients with rectal neuroendocrine tumors despite the frequent presence of lymphovascular invasion", J Gastroenterol, 50, pp.1184~1189 (2015)
  15. Kwon MJ, "Lymphovascular invasion in more than one-quarter of small rectal neuroendocrine tumors", World J Gastroenterol, 22, pp.9400~9410 (2016)
  16. Kang HS, "Lymphovascular invasion as a prognostic value in small rectal neuroendocrine tumor treated by local excision : a systematic review and meta-analysis", Pathol Res Pract, 215, pp.152642~ (2019)
  17. Shigematsu Y, "Recurrence 30 years after surgical resection of a localized rectal neuroendocrine tumor", Intern Med, 56, pp.1521~1525 (2017)
  18. Matsuhashi N, "Evaluation of treatment for rectal neuroendocrine tumors sized under 20mm in comparison with the WHO 2010 guidelines", Mol Clin Oncol, 7, pp.476~480 (2017)
  19. Lee SH, "Rectal neuroendocrine and L-cell tumors : diagnostic dilemma and therapeutic strategy", Am J Surg Pathol, 37, pp.1044~1052 (2013)
  20. Yamagishi D, "Clinicopathological characteristics of rectal carcinoid patients undergoing surgical resection", Oncol Lett, 4, pp.910~914 (2012)
  21. Fujimoto Y, "Lymph-node metastases in rectal carcinoids", Langenbecks Arch Surg, 395, pp.139~142 (2010)
  22. Okubo Y, "Risk factors associated with the progression and metastases of hindgut neuroendocrine tumors : a retrospective study", BMC Cancer, 17, pp.769~ (2017)
  23. Edge SB, "AJCC cancer staging manual" (2010), Springer
  24. Bosman FT, "WHO classification of tumours of the digestive system" (2010), International Agency for Research on Cancer
  25. Kudo S, "Endoscopic mucosal resection of flat and depressed types of early colorectal cancer", Endoscopy, 25, pp.455~461 (1993)
  26. Naunheim KS, "Rectal carcinoid tumors : treatment and prognosis", Surgery, 94, pp.670~676 (1983)
  27. Jann H, "Neuroendocrine tumors of midgut and hindgut origin : tumor-node-metastasis classification determines clinical outcome", Cancer, 117, pp.3332~3341 (2011)
  28. Caplin M, "ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms : colorectal neuroendocrine neoplasms", Neuroendocrinology, 95, pp.88~97 (2012)
  29. Shigeta K, "Long-term outcome of patients with locally resected high-and low-risk rectal carcinoid tumors", J Gastrointest Surg, 18, pp.768~773 (2014)
  30. 김광운, "직장 유암종의 내시경 절제: 효능과 추적 임상경과", Intestinal research, 9(3), pp.217~224 (2011), 대한장연구학회
  31. Kwak MS, "Long-term outcome of small, incidentally detected rectal neuroendocrine tumors removed by simple excisional biopsy compared with the advanced endoscopic resection during screening colonoscopy", Dis Colon Rectum, 61, pp.338~346 (2018)
  32. Sung HY, "Long-term prognosis of an endoscopically treated rectal neuroendocrine tumor : 10-year experience in a single institution", Eur J Gastroenterol Hepatol, 24, pp.978~983 (2012)

관련 논문AI추천

Long-term outcome of grade 1 rectal neuroendocrine tumor ≤1 cm after incomplete endoscopic resectionBumhee Park, Choong-Kyun Noh, Gil Ho Lee, Hye Lynn Jeon, Jong Hoon Park, Jong Sun Park, Kee Myung Lee, Sung Jae Shin, Sun Gyo Lim대한소화기내시경학회 · Clinical Endoscopy2025 · 제58권 제6호직장 신경내분비종양의 진단과 치료신현덕대한내과학회 · 대한내과학회지2014 · 제87권 제4호Endoscopic treatment for rectal neuroendocrine tumor: which method is better?Dong Hoon Baek, Seung Min Hong대한소화기내시경학회 · Clinical Endoscopy2022 · 제55권 제4호Gastric Neuroendocrine Tumors According to the 2019 World Health Organization Grading System: A Single-Center, Retrospective Study김범수, 육정환, 이진혁, 최기돈, 홍승모, Ahn Bokyung, Kim Yuri, Lee Jeong Hoon거트앤리버 소화기연관학회협의회 · Gut and Liver2023 · 제17권 제6호Prognostic Significance of Defining L-Cell Type on the Biologic Behavior of Rectal Neuroendocrine Tumors in Relation with Pathological Parameters주미, 강미선, 강윤경, 김경미, 김수진, 김우호, 김준미, 김현기, 문우성, 박도윤, 박양순, 손진희, 윤선옥, 이재혁, 장희경, 정은선, 조미연, 진소영, 최은희, 한혜승대한암학회 · Cancer Research and Treatment2015 · 제47권 제4호Clinical application of endoscopic ultrasonography in the management of rectal neuroendocrine tumors김성중, Hyoun Woo Kang, Soo-Young Na소화기인터벤션의학회 · International Journal of Gastrointestinal Intervention2023 · 제12권 제3호

이 간행물의 다른 논문 (18건)